argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 1 studies
| Studies (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-) | Trials (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-) | Recent Studies (post-2010) (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-) | Studies (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline) | Trials (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline) | Recent Studies (post-2010) (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline) |
|---|---|---|---|---|---|
| 14 | 0 | 2 | 1,216 | 0 | 229 |
| Protein | Taxonomy | argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- (IC50) | 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5781 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5781 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5781 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5781 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 2.909 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 2.909 | |
| Glutamate receptor 1 | Homo sapiens (human) | 6 | |
| Glutamate receptor 2 | Homo sapiens (human) | 2.5 | |
| Glutamate receptor 3 | Homo sapiens (human) | 1.9 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 2.909 | |
| Glutamate receptor 4 | Homo sapiens (human) | 1.1 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 2.909 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 2.909 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.2 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes-Rodrigues, J; Busnardo, C; Corrêa, FM; Tavares, RF | 1 |
1 other study(ies) available for argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
| Article | Year |
|---|---|
Cardiovascular effects of L-glutamate microinjection in the supraoptic nucleus of unanaesthetized rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Excitatory Amino Acid Antagonists; Ganglionic Blockers; Glutamic Acid; Heart Rate; Isoquinolines; Male; Microinjections; Pentolinium Tartrate; Quinoxalines; Rats; Rats, Wistar; Supraoptic Nucleus; Vasopressins | 2007 |